StocksMarket.in

Tag "Biotech"

 Breaking News

Bharat Biotech studying if Covaxin shot will work on Omicron

“Covaxin was developed against the original Wuhan variant,” a Bharat Biotech spokesperson told Reuters in a text message, referring to the Chinese city where the virus first emerged. Reuters November

Read Full Article

The Wall Street Journal: Blackstone to invest up to $250 million in British biotech company Autolus

Blackstone Inc. is investing as much as $ 250 million in U.K. biotechnology company Autolus Therapeutics PLC to fund the final stages of development of a new therapy to treat a serious form of

Read Full Article

Cannot cut corners#39; in approving Covaxin, says WHO, seeks more info from Bharat Biotech

File image of a vial of Covaxin vaccine The World Health Organisation (WHO) on Monday said it was expecting additional information from India’s Bharat Biotech regarding its COVID-19 jab Covaxin,

Read Full Article

Bharat Biotech awaits feedback from WHO for Covaxin EUL

The WHO is currently reviewing the data submitted by the vaccine maker and the date for a decision on the jab is yet “to be confirmed,” according to the update

Read Full Article

Windlas Biotech Standalone June 2021 Net Sales at Rs 110.96 crore, up 8.49% Y-o-Y

September 09, 2021 / 08:56 AM IST ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’] > 0){ // $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); // $ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); //}else if(resData[stkKey][‘percentchange’] = 0){ $ (‘#greentxt_’+articleId).removeClass(“redtxt”).addClass(“greentxt”); //$ (‘.arw_red’).removeClass(“arw_red”).addClass(“arw_green”); $ (‘#gainlosstxt_’+articleId).find(“.arw_red”).removeClass(“arw_red”).addClass(“arw_green”); }else

Read Full Article

Buzzing Stocks: RIL, Rossari Biotech, Wockhardt and other stocks in news today

Stocks In News: Check out the companies making the biggest headlines before the opening bell. Kaveri Seed Company | The company acquired 3,19,144 equity shares of itself at Rs 583.78

Read Full Article

Exclusive | SII, Bharat Biotech made additional 40-50 million doses of COVID-19 vaccine available in August

India achieved its highest daily vaccination and achieved the milestone of administering one core COVID-19 vaccine doses in one day

Read Full Article

Windlas Biotech IPO#39;s weak debut: Shares list at 5% discount to issue price

The pharma company has mobilised Rs 401.53 crore through its public issue that was subscribed 22.47 percent during August 4-6

Read Full Article

Windlas Biotech listing disappoints, Exxaro Tiles jumps 10%: What should investors do now?

Most experts Moneycontrol spoke to advise holding Windlas Biotech shares for the long term while short-term investors can book profits.

Read Full Article

Buzzing Stocks: Exxaro Tiles, Windlas Biotech, Lupin and other stocks in news today

Stocks In the News: Check out the companies making the biggest headlines before the opening bell. Exxaro Tiles | Plutus

Read Full Article

Windlas Biotech shares settle with 11.6% loss to issue price in debut trade

Cumulatively, Windlas Biotech traded with volume of 44.3 lakh equity shares on the BSE and NSE. ‘); $ (‘#lastUpdated_’+articleId).text(resData[stkKey][‘lastupdate’]); //if(resData[stkKey][‘percentchange’]

Read Full Article

Windlas Biotech IPO oversubscribed by 22.47 times, QIB portion booked 24.4 times on final day

Windlas Biotech IPO: Investors in the grey market traded shares of Windlas Biotech at a premium of Rs 90-110, the

Read Full Article

Windlas Biotech IPO: Retails investors lead charge, issue subscribed 7.06 times on Day 2

Windlas Biotech shares were trading at a premium of Rs 110-130 in the grey market, translating into a 23.9-28.3 percent

Read Full Article

Subscribe to Windlas Biotech: Prabhudas Lilladher

Prabhudas Lilladher has come out with its report on Windlas Biotech. The research firm has recommended to ”Subscribe” the ipo

Read Full Article

Windlas Biotech IPO: 10 key things to know before the issue opens

Windlas Biotech is amongst the top five players in the domestic pharmaceutical formulations CDMOs in terms of revenue, with focus

Read Full Article

Windlas Biotech IPO: Price band fixed at Rs 448-460, to raise Rs 401.53 crore

Windlas Biotech, the domestic pharmaceutical formulations contract development and manufacturing organization, has fixed the price band at Rs 448-460 per

Read Full Article

Windlas Biotech IPO to open on August 4, Tano India PE Fund to reduce entire stake

Windlas Biotech, one of the top five companies in the domestic pharmaceutical formulations contract development and manufacturing organization (CDMO), is

Read Full Article

Brazil scraps Covaxin#39;s EUA application after Bharat Biotech terminates pact with partners

The Brazilian health regulator’s decisioncomesafter the vaccine maker informed the South American country about thetermination of its pact with its

Read Full Article

Rossari Biotech: Calibrated inorganic strategy opens up opportunities

Rossari’s M&A strategy is apparently focussed on encompassing complementary technology, talent, products and client base COVID-19 pandemic aside, financial wealth

Read Full Article

Archives